Developmental Genetics of the Pharyngeal Apparatus
咽器的发育遗传学
基本信息
- 批准号:7851312
- 负责人:
- 金额:$ 41.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2012-06-30
- 项目状态:已结题
- 来源:
- 关键词:22q1122q11.2Animal ModelAortaBinding SitesBoxingCandidate Disease GeneCardiacCell CommunicationCell Culture TechniquesCell ProliferationCellsComplexCongenital AbnormalityCongenital Heart DefectsConsensusDataDefectDevelopmentDiGeorge SyndromeDistalEmbryoEmbryonic DevelopmentEtiologyFibroblast Growth FactorGene ExpressionGene Expression ProfilingGene FamilyGene TargetingGene Transfer TechniquesGenesGeneticGenetic TranscriptionHeartHeart AtriumHumanIn Situ HybridizationLungMammalian CellMediatingMesenchymeMesoderm CellMolecularMorphogenesisMusMuscleMutant Strains MiceMyocardialNeural CrestNeural Crest CellParathyroid glandPathway interactionsPatientsPharyngeal ApparatusPublic HealthReporterResearchReverse Transcriptase Polymerase Chain ReactionRight ventricular structureRoleShprintzen syndromeSignal TransductionStagingStructureSyndromeSystemTestingThymus GlandTissuesTranscription factor genesTretinoinWild Type Mousebasecell motilitycraniofacialdevelopmental geneticsgain of functiongene interactioninsightinterestmembermutantnovelprematureprogramstranscription factor
项目摘要
DESCRIPTION (provided by applicant): The development of the pharyngeal apparatus into the craniofacial region, thymus, parathyroid and cardiac outflow tract (OFT) involves complex gene interaction, making them highly sensitive to genetic and environmental insults. Velo-cardio-facial syndrome/DiGeorge syndrome is associated with hemizygous 22q11 deletions and characterized by defects in the derivatives of the pharyngeal apparatus. Tbx1, a T-box transcription factor, and the gene for VCFS/DGS in humans, is associated with defects in the same structures when inactivated in the mouse. The most serious defect in patients with the syndrome is OFT defects. Tbx1 is expressed in the multiple tissues in the pharyngeal apparatus including the second heart field (SHF) mesenchyme required for OFT development. The mouse serves as an excellent model organism to identify genes for OFT development because many aspects of its morphogenesis are shared with humans. To identify Tbx1 regulated genetic pathways in the SHF, we performed gene expression profiling of the caudal pharyngeal region in Tbx1-/- and wild type mouse embryos. Isl1, a key marker for the SHF, among selected others, were downregulated in Tbx1-/- mutants, while genes required for posterior specification of the first heart field (FHF), such as Raldh2, Gata4, and Tbx5, as well as a subset of atrial-specific muscle contractile genes were ectopically expressed. Opposite expression changes concomitant with SHF-derived cardiac defects occurred in TBX1 gain-of- function mutants. Based upon these data, we hypothesize that Tbx1 positively regulates SHF cell proliferation and restricts premature differentiation in the caudal pharyngeal mesenchyme. Several genes important for the retinoic acid pathway, transcription factors and novel genes were found in the microarrays. We propose to characterize the most biologically interesting genes in order to build the genetic pathway downstream of Tbx1 in the SHF using null, conditional loss- and gain-of-function mutant mouse embryos. To identify direct downstream target genes of Tbx1, reporter systems will be used in mammalian cells. Tissue interactions are required for neural crest cell (NCC) migration and OFT septation, defective in VCFS/DGS and mouse mutants. Recently, Crkl, another gene deleted on 22q11.2, was shown to mediate Fgf8 signaling downstream of Tbx1. To test this hypothesis in the SHF and in NCCs, embryos with pan-mesodermal and neural crest inactivation of Crkl, respectively, will be analyzed for altered expression of Fgf responsive genes and SHF genes characterized. Using genes identified by microarray studies and conditional mutants we will be able to dissect the genetic pathway of Tbx1 in the SHF and NCCs for OFT development from the pharyngeal apparatus. Narrative: The relevance of this research to public health is that this program will enable us to find genes that cause birth defects. By taking genetics approaches in model organisms, we can obtain insights that would otherwise not be possible in humans.
描述(由申请人提供):咽器发育为颅面区、胸腺、甲状旁腺和心脏流出道(OFT)涉及复杂的基因相互作用,使其对遗传和环境损伤高度敏感。Velo-cardio-facial综合征/DiGeorge综合征与半合子22 q11缺失相关,特征为咽器衍生物缺陷。Tbx 1是一种T-box转录因子,也是人类VCFS/DGS的基因,当在小鼠中失活时,与相同结构的缺陷相关。该综合征患者最严重的缺陷是OFT缺陷。Tbx 1在咽器的多种组织中表达,包括OFT发育所需的第二心脏区域(SHF)间充质。小鼠作为一个很好的模式生物,以确定基因的OFT发展,因为它的形态发生的许多方面与人类共享。为了确定Tbx 1调节的遗传途径在SHF,我们进行了基因表达谱的尾部咽部区域Tbx 1-/-和野生型小鼠胚胎。Isl 1是SHF的关键标志物,在Tbx 1-/-突变体中下调,而第一心野(FHF)后向特异性所需的基因,如Raldh 2,Gata 4和Tbx 5,以及心房特异性肌肉收缩基因的子集异位表达。TBX 1功能获得性突变体伴随SHF衍生的心脏缺陷发生相反的表达变化。基于这些数据,我们假设Tbx 1正调控SHF细胞增殖,并限制在尾咽间充质的过早分化。在微阵列中发现了几个对维甲酸途径重要的基因、转录因子和新基因。我们建议,以建立Tbx 1在SHF使用空,条件性丧失和获得功能突变小鼠胚胎的遗传途径下游的最具生物学意义的基因的特征。为了鉴定Tbx 1的直接下游靶基因,将在哺乳动物细胞中使用报告系统。神经嵴细胞(NCC)的迁移和OFT分隔,在VCFS/DGS和小鼠突变体缺陷的组织相互作用是必需的。最近,在22q11.2上缺失的另一个基因Crkl被证明介导Tbxl下游的Fgf 8信号传导。为了在SHF和NCC中检验这一假设,将分别分析具有Crkl的全中胚层和神经嵴失活的胚胎的Fgf应答基因的改变的表达,并表征SHF基因。使用微阵列研究和条件突变体鉴定的基因,我们将能够解剖Tbx 1在SHF和NCC中的遗传途径,用于从咽器发育OFT。这项研究与公共卫生的相关性在于,这项计划将使我们能够找到导致出生缺陷的基因。通过在模式生物中采用遗传学方法,我们可以获得在人类中不可能获得的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BERNICE E MORROW其他文献
BERNICE E MORROW的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BERNICE E MORROW', 18)}}的其他基金
Molecular pathogenesis of congenital heart disease mediated by neural crest and second heart field cells
神经嵴和第二心野细胞介导先天性心脏病的分子发病机制
- 批准号:
10621288 - 财政年份:2022
- 资助金额:
$ 41.16万 - 项目类别:
Genetic modifiers of congenital heart disease in 22q11.2 deletion syndrome
22q11.2缺失综合征先天性心脏病的遗传修饰
- 批准号:
10373375 - 财政年份:2022
- 资助金额:
$ 41.16万 - 项目类别:
Genetic modifiers of congenital heart disease in 22q11.2 deletion syndrome
22q11.2缺失综合征先天性心脏病的遗传修饰
- 批准号:
10553279 - 财政年份:2022
- 资助金额:
$ 41.16万 - 项目类别:
Molecular pathogenesis of congenital heart disease mediated by neural crest and second heart field cells
神经嵴和第二心野细胞介导先天性心脏病的分子发病机制
- 批准号:
10435713 - 财政年份:2022
- 资助金额:
$ 41.16万 - 项目类别:
Molecular and cellular mechanisms in cardiac outflow tract formation and defects
心脏流出道形成和缺陷的分子和细胞机制
- 批准号:
10289982 - 财政年份:2021
- 资助金额:
$ 41.16万 - 项目类别:
Molecular and cellular mechanisms in cardiac outflow tract formation and defects
心脏流出道形成和缺陷的分子和细胞机制
- 批准号:
10471433 - 财政年份:2021
- 资助金额:
$ 41.16万 - 项目类别:
Cell fate choices by Tbx1 in forming the mammalian heart
Tbx1 在形成哺乳动物心脏过程中的细胞命运选择
- 批准号:
10615781 - 财政年份:2020
- 资助金额:
$ 41.16万 - 项目类别:
相似国自然基金
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
- 批准号:82370906
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
22q11.2微缺失综合症中T盒转录因子Tbx1与信号接头蛋白Crkl遗传相互作用致肺动脉发育不良缺陷的机制研究
- 批准号:81170153
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
基于染色体22q11.2候选基因与腭心面综合征表型的分子诊断研究
- 批准号:81070813
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
无22q11.2区基因微缺失的心脏圆锥动脉干畸形患者中新TBX1突变体蛋白的功能研究
- 批准号:81070135
- 批准年份:2010
- 资助金额:32.0 万元
- 项目类别:面上项目
染色体22q11.2区域泌尿系统畸形关键致病基因的克隆与鉴定
- 批准号:30571867
- 批准年份:2005
- 资助金额:25.0 万元
- 项目类别:面上项目
相似海外基金
成人期へtransitionする22q11.2欠失症候群患者の移行支援プログラムの構築
为 22q11.2 缺失综合征患者过渡到成年期建立过渡支持计划
- 批准号:
24K13915 - 财政年份:2024
- 资助金额:
$ 41.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An Engineered Hydrogel Platform to Improve Neural Organoid Reproducibility for a Multi-Organoid Disease Model of 22q11.2 Deletion Syndrome
一种工程水凝胶平台,可提高 22q11.2 缺失综合征多器官疾病模型的神经类器官再现性
- 批准号:
10679749 - 财政年份:2023
- 资助金额:
$ 41.16万 - 项目类别:
重複障害を呈する医療的ケア児と家族の移行期における意思決定支援のPPI型研究
多重残疾儿童及其家庭过渡期决策支持的PPI型研究
- 批准号:
23H02834 - 财政年份:2023
- 资助金额:
$ 41.16万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Outcomes and disease burden in a model of young adult multimorbidity
年轻成人多重病模型的结果和疾病负担
- 批准号:
479042 - 财政年份:2023
- 资助金额:
$ 41.16万 - 项目类别:
Operating Grants
22q11.2欠失症候群との網羅的な比較検討によるファロー四徴症での遺伝子異常の解明
与22q11.2缺失综合征综合比较阐明法洛四联症遗传异常
- 批准号:
23K08237 - 财政年份:2023
- 资助金额:
$ 41.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating abnormalities in top-down cortical processing and behavior in a model of the 22q11.2 deletion
研究 22q11.2 缺失模型中自上而下的皮质处理和行为的异常
- 批准号:
10649058 - 财政年份:2023
- 资助金额:
$ 41.16万 - 项目类别:
Phenotypic convergence at mitochondria in copy number variant disorders
拷贝数变异性疾病中线粒体的表型趋同
- 批准号:
10723885 - 财政年份:2023
- 资助金额:
$ 41.16万 - 项目类别:
Neurodevelopmental defects of the thalamocortical pathway as a convergent feature of psychiatric disorders
丘脑皮质通路的神经发育缺陷是精神疾病的共同特征
- 批准号:
10655225 - 财政年份:2023
- 资助金额:
$ 41.16万 - 项目类别:
Improving Genetic Diagnosis for African Ancestry Populations
改善非洲血统人群的基因诊断
- 批准号:
10736833 - 财政年份:2023
- 资助金额:
$ 41.16万 - 项目类别:
The schizophrenia-associated 3q29 deletion: genetic architecture of behavioral phenotypes
精神分裂症相关的 3q29 缺失:行为表型的遗传结构
- 批准号:
10579244 - 财政年份:2023
- 资助金额:
$ 41.16万 - 项目类别:














{{item.name}}会员




